DeepHealth Inc., an AI-powered health informatics company and a wholly owned subsidiary of RadNet, Inc. (RDNT), has officially launched Reporting Pro, a next-generation reporting platform that integrates speech recognition, AI findings, measurements, AI-generated impressions, and quality checks into a single workflow at RSNA 2025 and is now available for commercial use.
The company says Reporting Pro is designed to help radiologists work more efficiently at a time when imaging volumes are rising and workforce shortages are expected to worsen. In the United States, the radiologist shortage is protected to reach about 15% by 2029, with some European countries facing shortages of up to 40% by 2030.At its core, Reporting Pro brings together several key capabilities:
-Clinical AI integration: The platform pulls in AI-generated findings and measurements from FDA-cleared and CE-marked DeepHealth and third-party tools directly into structured reports.
-Generative AI-powered reporting: Reporting Pro uses AI to help organize findings and draft impressions, adapting over time based on physician feedback to improve clarity and consistency.
-Faster deployment: The system supports migration of existing templates and reporting preferences, helping radiologists maintain familiar workflows while adopting AI-enhanced tools.
-Unified workflow: Speech recognition, AI findings, measurements, impressions, and quality assurance are combined into one connected reporting environment, reducing manual steps and data transfer.
Madhu Jahagirdar, Business and Product Leader, Enterprise Imaging, at DeepHealth, said the launch marks a major shift in how radiologists can use AI-not just for image analysis, but throughout the entire reporting process. He noted that the goal is to let radiologists focus on reviewing and refining results rather than spending time on manual documentation.
Reporting Pro aims to help radiology teams handle growing workloads more efficiently while maintaining high clinical quality, offering a more streamlined and intelligent reporting experience for physicians and their referring clinicians.
RBDT has traded between $50.76 and $85.84 over the past year. The stock closed Tuesday's trading at $56.18, up 3.73%. In pre-market trading the stock is at $55.68, down 0.89%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.